Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amantadine”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Not applicableUnknownNCT04173832
What this trial is testing

Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

Who this might be right for
L-DOPA-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableUnknownNCT01338662
What this trial is testing

Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

Who this might be right for
Parkinson's Disease
Seoul National University Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Post-approval studies (Phase 4)Study completedNCT01071395
What this trial is testing

Validation of Dyskinesia Rating Scales

Who this might be right for
Parkinson's Disease
Rush University Medical Center 68
Post-approval studies (Phase 4)Ended earlyNCT00975611
What this trial is testing

Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation

Who this might be right for
SchizophreniaSchizoaffective Disorder
David C. Henderson, MD 6
Post-approval studies (Phase 4)UnknownNCT01313819
What this trial is testing

The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy

Who this might be right for
Parkinson's DiseaseFreezing of Gait
Seoul National University Hospital 20
Large-scale testing (Phase 3)Study completedNCT02202551
What this trial is testing

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 223
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06817200
What this trial is testing

The Effect of Amantadine as add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial

Who this might be right for
Parkinson Disease (PD)
University Hospital, Toulouse 132
Not applicableUnknownNCT02566720
What this trial is testing

Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study

Who this might be right for
Acquired Brain InjuryComaPersistent Vegetative State+2 more
Hamilton Health Sciences Corporation 10
Testing effectiveness (Phase 2)Study completedNCT06055244
What this trial is testing

Amantadine Therapy for Cognitive Impairment in Long COVID

Who this might be right for
Long COVIDPost-COVID19 ConditionPost-Acute COVID19 Syndrome
Ohio State University 64
Large-scale testing (Phase 3)Study completedNCT02136914
What this trial is testing

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease
Adamas Pharmaceuticals, Inc. 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT06443827
What this trial is testing

Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness

Who this might be right for
AmantadineConsciousness DisordersElectroencephalography
Azienda Sanitaria dell'Alto Adige 18
Large-scale testing (Phase 3)Study completedNCT00821691
What this trial is testing

Action of Amantadine on Post-Stroke Aphasic Patients

Who this might be right for
Cerebral Infarction
Centre Hospitalier Universitaire de Nice 50
Testing effectiveness (Phase 2)Study completedNCT00199719
What this trial is testing

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

Who this might be right for
Chronic Hepatitis C
University Hospital, Limoges 30
Large-scale testing (Phase 3)UnknownNCT04854759
What this trial is testing

The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms

Who this might be right for
COVID-19SARS-CoV-2
Independent Public Clinical Hospital No. 4 in Lublin 200
Not applicableStudy completedNCT07113015
What this trial is testing

A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Tremor
Multan Medical And Dental College 220
Post-approval studies (Phase 4)Ended earlyNCT04273737
What this trial is testing

Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy

Who this might be right for
Cerebral Palsy
Columbia University 11
Large-scale testing (Phase 3)Study completedNCT01397422
What this trial is testing

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

Who this might be right for
DyskinesiaLevodopa Induced DyskinesiaParkinson's Disease
Adamas Pharmaceuticals, Inc. 83
Load More Results